Therapeutics
Total Trials
16
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,898
NCT04689308
This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 7, 2021
Completion: Oct 1, 2023
NCT04815148
MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis
Start: Apr 1, 2021
Completion: Mar 31, 2022
NCT07182864
MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis
Phase: Phase 1/2
Start: Jan 6, 2022
Completion: Oct 8, 2022
NCT05642949
Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors
Start: Jan 23, 2023
Completion: Jun 30, 2026
NCT05652855
Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors
Completion: Jul 31, 2026
NCT06373406
A Study of MHB036C for Advanced Solid Tumor
Start: May 18, 2023
Completion: Dec 31, 2024
NCT07185282
A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis
Phase: Phase 3
Start: Jun 10, 2023
Completion: Aug 15, 2025
NCT07181187
Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
Phase: Phase 2
Start: Mar 26, 2024
Completion: May 14, 2026
NCT06345482
A Study of MHB039A for Advanced Solid Tumor
Start: Apr 1, 2024
Completion: Jun 1, 2029
NCT07045454
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
Start: Mar 31, 2025
Completion: Mar 31, 2031
NCT06985355
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
Start: Jul 17, 2025
Completion: May 31, 2031
NCT06989918
MHB018A Treatment in Patients With Active Thyroid Eye Disease
Start: Aug 1, 2025
Completion: Jul 31, 2028
NCT07126665
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Start: Aug 31, 2025
Completion: Aug 31, 2031
NCT07130383
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Start: Sep 30, 2025
NCT07192107
A Study of MHB042C in Patients With Advanced Solid Tumors
Start: Oct 31, 2025
Completion: Oct 31, 2029
NCT07192120
A Study of MHB048C in Patients With Advanced Solid Tumors
Loading map...